ClinicalTrials.Veeva

Menu

Early Detection of Vaping-related Vascular Diseases (ENDS)

University of Miami logo

University of Miami

Status

Enrolling

Conditions

Blood Vessel Injury
Vaping

Study type

Observational

Funder types

Other

Identifiers

NCT05454267
20211060

Details and patient eligibility

About

The purpose of this study is to determine how vaping affects blood vessels, in particular if early damage occurs in the lung vessels.

Enrollment

90 estimated patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Vapers Group:

  1. Current electronic cigarette (EC) Puff Bar users defined as using EC either daily or occasionally in the past 30 days for at least 6 months, and with 5% nicotine concentration pods.
  2. Adults aged 18-40 years

Healthy Group:

  1. Healthy never smokers, never vapers
  2. Adults aged 18-40 years

Exclusion criteria

  1. Current or past smoking of tobacco cigarette (TC) or other tobacco/nicotine products (e.g., smokeless tobacco, Hookah) or marijuana will be excluded from the study.
  2. Subjects with self-reported history of chronic health problems including asthma, chronic obstructive pulmonary disease (COPD), morbid obesity (BMI>40 kg/m2), hypertension or diabetes
  3. Pregnant or breastfeeding women

Trial design

90 participants in 3 patient groups

Healthy Volunteer Group
Description:
Participants who have never smoked or vaped
High Frequency Vaping Group
Description:
Participants who vape \>20 days per month.
Low-Frequency Vaping Group
Description:
Participants who vape \< 20 days per month

Trial contacts and locations

1

Loading...

Central trial contact

Michael Campos, MD; Adam Wanner, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems